Browse All

Current Filters

CLEAR FILTER x

TITLE

Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial

Author:Pozo-Rosich, Patricia   Ailani, Jessica   Ashina, Messoud   Goadsby, Peter   Lipton, Richard   Reuter, Uwe   Guo, Hua   Schwefel, Brittany   Boinpally, Ramesh   McCusker, Emily   Yu, Sung Yun   Finnegan, Michelle   Trugman, Joel   

Session Name:S47: Advances in Migraine Therapeutics  

Topic:Headache  

Program Number:S47.005  

Author Institution:Vall d’Hebron University Hospital & Vall d’Hebron Institute of Research, Universitat Autonoma of Barcelona, Barcelona, Spain  Georgetown Headache Center, Georgetown University Hospital, McLean, VA  Danish Headache Center, Rigshospitalet Glostrup, University of Copenhagen, Glostrup, Denmark  NIHR-Wellcome Trust King's Clinical Research Facility, King's College London & University of California, Los Angeles, CA  Albert Einstein College of Medicine, Bronx, NY  Department of Neurology, Charité-Universitätsmedizin Berlin & Universitätsmedizin Greifswald, Berlin, Germany  AbbVie, Madison, NJ  AbbVie, North Chicago, IL  AbbVie, Madison , NJ  

Sensorineural Hearing Loss From Capnocytophaga canimorsus Meningitis in an Immunocompetent Patient

Author:Villar, Manny   Reyes, Cleo Zarina   Menon, Ajay   Rehim, Erafat   Clauser, Gary   

Session Name:P2: Infectious Disease: Bacterial Infections 2  

Topic:Infectious Disease  

Program Number:P2.004  

Author Institution:University of South Florida, Morsani College of Medicine, Tampa, FL  Lehigh Valley Health Network, Allentown, PA  

Unique Patterns of Ischemic Stroke from Combined Cocaine and Heroin Use: A Case Series

Author:Hasan, Zachariah   Pinna, Pranusha   Lynch, John   Kim, Yongwoo   

Session Name:P3: Cerebrovascular Disease and Interventional Neurology: Interesting Cases 2  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P3.031  

Author Institution:MedStar Georgetown University Hospital, Mclean, VA  NIH/NINDS, Bethesda, MD  NINDS, Bethesda, MD  MedStar Washington Hospital Center, Washington, DC  

RT-QuIC Testing for Prions: Applying a Sensitive but Imperfect Test in Clinical Practice

Author:Jones, Samuel   Lazar, Evelyn   Porter, Amanda   Prusinski, Christian   Brier, Matthew   Bucelli, Robert   Day, Gregory   

Session Name:P5: Behavioral and Cognitive Neurology in Clinical Practice  

Topic:Behavioral and Cognitive Neurology  

Program Number:P5.010  

Author Institution:Mayo Clinic, Jacksonville, FL  JFK Medical Center, Edison, NJ  Washington University, Saint Louis, MO  

Long-Term Follow-Up of Onasemnogene Abeparvovec Gene Therapy in Patients with Spinal Muscular Atrophy Type 1

Author:Mendell, Jerry   Wigderson, Melissa   Alecu, Iulian   Yang, Lina   Mehl, Lesa   Connolly, Anne   

Session Name:P7: Child Neurology and Developmental Neurology: Spinomuscular Atrophy/Muscular Dystrophies  

Topic:Child Neurology and Developmental Neurology  

Program Number:P7.006  

Author Institution:Center for Gene Therapy, Nationwide Children’s Hospital, Columbus, OH  Novartis Gene Therapies, Inc., Bannockburn, IL  Novartis Pharmaceuticals, Basel, Switzerland  Novartis Gene Therapies, Inc., East Hanover, NJ  Novartis Institutes for BioMedical Research, Cambridge, MA  Nationwide Children's Hospital, Columbus, OH